BVNRY Overview
Upcoming Projects (BVNRY)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BVNRY)
-
A second look at the current treatment landscape of RSV with a focus on Bavarian Nordic's MVA-BN RSV and GSK's newly approved Arexvy
Tickers: BVNRY, GSK
Executed On: Jul 06, 2023 at 09:00 AM EDT -
A look at the current treatment landscape of RSV with a focus on Bavarian Nordic's MVA-BN RSV and GSK's newly approved Arexvy
Tickers: GSK, BVNRY
Executed On: Jun 14, 2023 at 03:00 PM EDT -
A fourth look at the concerns and treatment needs of monkeypox
Ticker: BVNRY
Executed On: Aug 22, 2022 at 09:00 AM EDT -
A third look at the concerns and treatment needs of monkeypox
Ticker: BVNRY
Executed On: Aug 12, 2022 at 09:00 AM EDT -
Discussing the efficacy of Bavarian Nordic's vaccine and the overall concern for Monkeypox outbreak: A first look at the concerns and treatment needs of monkeypox
Ticker: BVNRY
Executed On: Jul 29, 2022 at 04:30 PM EDT
Upcoming & Overdue Catalysts (BVNRY)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (BVNRY)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
